Cuu Long Pharmaceutical JSC (HOSE:DCL)
32,950
+2,150 (6.98%)
At close: Oct 31, 2025
HOSE:DCL Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Jan '21 Jan 1, 2021 | 2016 - 2020 |
Net Income | 34,784 | 53,571 | 61,717 | 111,641 | 85,961 | 66,391 | Upgrade |
Depreciation & Amortization | 48,738 | 37,856 | 38,278 | 38,135 | 34,273 | 28,280 | Upgrade |
Other Amortization | 401.69 | 401.69 | - | - | - | - | Upgrade |
Loss (Gain) From Sale of Assets | -99.18 | - | -8,884 | -25,617 | -43,737 | -71,458 | Upgrade |
Other Operating Activities | 1,664 | -5,065 | 5,872 | 7,005 | -4,989 | 44,242 | Upgrade |
Change in Accounts Receivable | -8,341 | 8,662 | -14,709 | -384,124 | -105,671 | 50,453 | Upgrade |
Change in Inventory | -16,488 | 16,311 | -55,033 | -9,758 | -83,805 | -13,409 | Upgrade |
Change in Accounts Payable | -32,725 | -27,074 | -1,479 | -161,826 | 214,295 | -12,826 | Upgrade |
Change in Other Net Operating Assets | -9,749 | -4,850 | -3,233 | -1,001 | 3,380 | 1,693 | Upgrade |
Operating Cash Flow | 18,187 | 69,813 | 22,530 | -450,071 | 29,437 | 93,366 | Upgrade |
Operating Cash Flow Growth | - | 209.86% | - | - | -68.47% | 23.54% | Upgrade |
Capital Expenditures | -76,278 | -172,850 | -222,874 | -233,028 | -152,612 | -101,948 | Upgrade |
Sale of Property, Plant & Equipment | - | - | 370.64 | 250.12 | - | 171.36 | Upgrade |
Investment in Securities | - | - | 44,346 | 292,923 | - | - | Upgrade |
Other Investing Activities | 4,322 | 6,467 | 9,151 | 33,032 | 56,947 | 74,835 | Upgrade |
Investing Cash Flow | -99,310 | -166,382 | -169,006 | 93,177 | 224,393 | -66,536 | Upgrade |
Long-Term Debt Issued | - | 1,199,477 | 973,672 | 1,218,898 | 2,427,584 | 2,014,758 | Upgrade |
Long-Term Debt Repaid | - | -1,075,364 | -856,533 | -1,205,603 | -2,702,031 | -2,014,209 | Upgrade |
Net Debt Issued (Repaid) | 80,926 | 124,113 | 117,138 | 13,295 | -274,447 | 548.85 | Upgrade |
Issuance of Common Stock | - | - | - | 355,205 | 20,000 | - | Upgrade |
Financing Cash Flow | 80,926 | 124,113 | 117,138 | 368,500 | -254,447 | 548.85 | Upgrade |
Foreign Exchange Rate Adjustments | 33.32 | 8.1 | 2.59 | -8.99 | -5.76 | 0.08 | Upgrade |
Net Cash Flow | -163.64 | 27,552 | -29,335 | 11,596 | -622.67 | 27,379 | Upgrade |
Free Cash Flow | -58,091 | -103,037 | -200,343 | -683,099 | -123,174 | -8,582 | Upgrade |
Free Cash Flow Margin | -3.98% | -7.89% | -17.51% | -67.25% | -17.51% | -1.28% | Upgrade |
Free Cash Flow Per Share | -812.61 | -1410.67 | -2742.89 | -9736.25 | -2142.18 | -151.01 | Upgrade |
Cash Interest Paid | 25,437 | 25,437 | 29,199 | 35,991 | 33,237 | 25,943 | Upgrade |
Cash Income Tax Paid | 14,964 | 14,964 | 12,576 | 25,261 | 33,440 | 14,532 | Upgrade |
Levered Free Cash Flow | -9,416 | -134,124 | -187,565 | -814,492 | -31,418 | -68,051 | Upgrade |
Unlevered Free Cash Flow | 17,248 | -118,190 | -168,484 | -789,725 | -8,753 | -47,261 | Upgrade |
Change in Working Capital | -67,302 | -16,951 | -74,453 | -581,234 | -42,071 | 25,911 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.